Jonathan Barratt, PhD, FRCP - In Pursuit of Proteinuria: Novel Therapeutic Approaches in the Management of IgAN

Visit https://www.peervoice.com/APY860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - In Pursuit of Proteinuria: Novel Therapeutic Approaches in the Management of IgAN”, participants will be able to: Recognize the role of endothelin-1 (ET1) and angiotensin-II (Ang II) signaling pathways in the progression of immunoglobulin A nephropathy (IgAN); Evaluate clinical evidence for emerging strategies for targeting proteinuria in IgAN, including endothelin-1 and angiotensin-II receptor antagonism; and Apply current guidelines and tools in day-to-day clinical practice to predict and improve prognosis in patients with IgAN.